State Board of Administration of Florida Retirement System
RAPP

State Board of Administration of Florida Retirement System’s Rapport Therapeutics RAPP Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$207K Buy
+6,612
New +$186K ﹤0.01% 1872

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

State Board of Administration of Florida Retirement System's RAPP Position: Q1 2026 in Review

State Board of Administration of Florida Retirement System opened a new position in Rapport Therapeutics (RAPP) in Q1 2026: 6,612 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #1872 among its holdings.

147 funds tracked by Wall St. Rank hold RAPP as of Q1 2026.

  • State Board of Administration of Florida Retirement System held 6,612 shares of Rapport Therapeutics worth $207K as of Q1 2026.
  • Rapport Therapeutics was a new State Board of Administration of Florida Retirement System position in Q1 2026.
  • Rapport Therapeutics made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q1 2026, its #1872 holding.
  • 147 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q1 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2026, filed 8 May 2026.